glutamine has been researched along with cb-839 in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 19 (63.33) | 24.3611 |
2020's | 11 (36.67) | 2.80 |
Authors | Studies |
---|---|
Birsen, R; Bouscary, D; Chapuis, N; Decroocq, J; Demo, S; Hospital, MA; Jacque, N; Joseph, L; Lacombe, C; Lambert, M; Larrue, C; Maciel, TT; Mayeux, P; Meunier, G; Moura, IC; Poulain, L; Recher, C; Ronchetti, AM; Saland, E; Sarry, JE; Sujobert, P; Tamburini, J; Willems, L | 1 |
Chen, G; Guo, E; Guo, L; Liu, Z; Lu, H; Shan, W; Wang, C; Xia, M; Xu, Y; Zhou, B | 1 |
Alt, J; Chen, B; Elgogary, A; Fu, J; Hanes, J; Hartung, T; Le, A; Lee, R; Liu, Y; Neisser, M; Nguyen, C; Park, JK; Poore, B; Rais, R; Reyes, J; Rojas, C; Semenza, GL; Slusher, BS; Tsukamoto, T; Xia, S; Xu, Q; Zhao, L; Zimmermann, SC | 1 |
Baran, N; Cai, T; Chan, SM; Davis, RE; DiNardo, C; Flores, ER; Gonzalez, D; Haferlach, T; Jacamo, R; Konoplev, S; Konopleva, M; Li, W; Lodi, A; Ma, H; Majeti, R; Matre, P; Qi, Y; Samudio, I; Schimmer, AD; Su, X; Sweeney, SR; Tiziani, S; Velez, J; Wang, T | 1 |
Bailey, ST; Braas, D; Christofk, HR; Czernin, J; Demo, S; Dubinett, SM; Emberley, E; Fishbein, MC; Garon, E; Graeber, T; Gross, M; Jackson, NJ; Janes, J; Krysan, K; Lee, JT; Mackinnon, A; Magyar, C; Momcilovic, M; Pan, A; Parlati, F; Rodriguez, M; Sadeghi, S; Shackelford, DB; Walser, TC; Works, M; Zhang, W | 1 |
D'Alessandro, A; DeGregori, J; Gregory, MA; Hansen, KC; Nemkov, T; Reisz, JA; Zaberezhnyy, V | 1 |
Banerjee, S; Barnes, S; Cui, H; Dubey, S; Ge, J; Guo, S; Liu, G; Xie, N | 1 |
Abu Aboud, O; Chaudhari, AJ; Habib, SL; Liang, S; Stewart, B; Sutcliffe, J; Trott, J; Weiss, RH | 1 |
Bhattacharya, PK; Dutta, P; Jones, LW; Lee, J; Lee, Y; McCullough, C; McHenry, J; Nguyen, L; Norton, W; Shanmugavelandy, S; Zacharias, NM | 1 |
Cerione, RA; Huang, Q; Iyer, P; Katt, WP; McDermott, LA; O'Neill, J; Reimer, S; Stalnecker, C; Zhang, C | 1 |
Diggs, L; Hatzivassiliou, G; Kimmelman, AC; Li, Z; Parker, SJ; Rais, R; Skolnik, EY; Slusher, BS; Somlo, S; Soomro, I; Sun, Y; Thomas, AG | 1 |
Braun, AL; Huang, Y; Li, Y; Liu, J; Peer, J; Tong, Z; Wang, Y; Wu, B; Zhao, L; Zhao, R; Zheng, JC | 1 |
Addie, RD; Bovée, JVMG; Cleton-Jansen, AM; Cleven, AHG; de Jong, Y; Kruisselbrink, AB; Molenaar, RJ; Niessen, B; Peterse, EFP; van den Akker, BEWM | 1 |
Badran, K; Bailey, ST; Bernthal, NM; Braas, D; Christofk, HR; Demo, S; Dubinett, SM; Federman, N; Fishbein, MC; Fridman, D; Go, J; Graeber, TG; Gricowski, M; Ibarra, J; Lee, JT; Li, R; Momcilovic, M; Parlati, F; Phelps, ME; Sadeghi, S; Shackelford, DB; Shuman, R; St John, M; Walser, TC; Yanagawa, J | 1 |
Boysen, G; Davis, MA; Dings, RPM; Griffin, RJ; Jamshidi-Parsian, A; Kore, RA; Siegel, ER; Simecka, CM | 1 |
Bass, AJ; Beeson, CC; Beeson, GC; Diehl, JA; Ogretmen, B; Oleinik, N; Parnham, S; Qie, S; Rustgi, AK; Wong, KK; Yoshida, A | 1 |
Adamoski, D; Consonni, SR; Corrêa-da-Silva, F; Dias, SMG; Malta de Sá Patroni, F; Meira Dias, M; Mendes de Moraes-Vieira, PM; Ornitz Oliveira Souza, R; Reis, LMD; Rodrigues Ascenção, CF; Silber, AM; Sousa de Oliveira, KR | 1 |
Binici, A; Brand, S; Ceballos, J; Choidas, A; Karageorgis, G; Knauer, L; Nowacki, J; Reckzeh, ES; Schwalfenberg, M; Stroet, MCM; Strohmann, C; Waldmann, H; Ziegler, S | 1 |
Hong, SE; Hong, YJ; Jang, SK; Jin, HO; Kim, H; Kim, JY; Kim, YS; Lee, JK; Oh, AC; Park, IC; Sim, JH | 1 |
Cerione, RA; Erickson, JW; Li, Y; Nguyen, TT; Ramachandran, S; Stalnecker, CA | 1 |
Burrows, M; Finan, JM; Gade, TPF; Gong, YY; Huangyang, P; Khare, S; Lee, P; Malik, D; Nissim, I; Perkons, N; Rhoades, S; Simon, MC; Weljie, AM | 1 |
Baguley, BC; Dechaume, AL; Katt, WP; Leung, EY; Murray, PM; Singleton, DC | 1 |
Asaka, R; Asaka, S; Attarwala, N; Chen, X; Chen, YW; Chuang, CM; Davidson, B; DeMarzo, AM; Gaillard, S; Hong, J; Hsu, FC; Jung, JG; Le, A; Shen, YA; Shih, IM; Suryo Rahmanto, Y; Tomaszewski, A; Wang, TL; Yen, TT; Zhang, C | 1 |
Bajor, DL; Chen, Y; Selfridge, JE; Wang, Z; Zhao, Y | 1 |
Beijersbergen, R; Berkers, CR; Bernards, R; Bosma, A; Isima, N; Jin, G; Jin, H; Jochems, F; Lieftink, C; Qin, W; Wang, C; Wang, S; Wu, H; Zaal, EA | 1 |
Janowitz, T; Lukey, MJ; Qiu, Y; Stamatatos, O; Yang, WH | 1 |
Chen, J; Dang, R; Emberley, E; Gross, M; Huang, T; Li, W; MacKinnon, A; Pan, A; Parlati, F; Singh, D; Sotirovska, N; Steggerda, SM; Wang, T | 1 |
Baek, GH; Choi, YJ; Jeon, JS; Kang, KW; Kim, S; Kim, SK | 1 |
Adhikary, G; Chen, X; Eckert, RL; Emadi, A; Friedberg, JS; Naselsky, W; Newland, JJ; Shrestha, S; Xu, W | 1 |
Bader, JE; Chi, C; Fisher, EL; Hathaway, ES; Karijolich, J; Landis, MD; Madden, MZ; Muka, JE; Needle, GA; O'Neil, RT; Patterson, AR; Philip, M; Rathmell, JC; Reinfeld, BI; Wolf, MM; Ye, X | 1 |
1 review(s) available for glutamine and cb-839
Article | Year |
---|---|
Enhancing the Efficacy of Glutamine Metabolism Inhibitors in Cancer Therapy.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Benzeneacetamides; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Clinical Trials as Topic; Disease Models, Animal; Drug Resistance, Neoplasm; Glutaminase; Glutamine; Humans; Neoplasms; NF-E2-Related Factor 2; Oxidative Stress; Thiadiazoles; Tumor Escape; Tumor Microenvironment | 2021 |
29 other study(ies) available for glutamine and cb-839
Article | Year |
---|---|
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzeneacetamides; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Citric Acid Cycle; Enzyme Inhibitors; Gene Knockdown Techniques; Glutaminase; Glutamine; Humans; Leukemia, Myeloid, Acute; Mice; Mitochondria; Oxidative Phosphorylation; Oxygen Consumption; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Thiadiazoles; Xenograft Model Antitumor Assays | 2015 |
Blockage of glutaminolysis enhances the sensitivity of ovarian cancer cells to PI3K/mTOR inhibition involvement of STAT3 signaling.
Topics: Antineoplastic Agents; Apoptosis; Benzeneacetamides; Blotting, Western; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Flow Cytometry; Gene Knockdown Techniques; Glutaminase; Glutamine; Humans; Indoles; Ovarian Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Purines; Real-Time Polymerase Chain Reaction; Signal Transduction; STAT3 Transcription Factor; Thiadiazoles; TOR Serine-Threonine Kinases | 2016 |
Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzeneacetamides; Cell Line, Tumor; Glutaminase; Glutamine; Humans; Metformin; Mice; Nanoparticles; Pancreatic Neoplasms; Proto-Oncogene Proteins p21(ras); Sulfides; Thiadiazoles; Xenograft Model Antitumor Assays | 2016 |
Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes.
Topics: Antineoplastic Agents; Apoptosis; Benzeneacetamides; Cell Differentiation; Cell Proliferation; Energy Metabolism; Enzyme Inhibitors; Glutamate Dehydrogenase; Glutamic Acid; Glutaminase; Glutamine; Glutarates; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Mutation; Protein Isoforms; Sulfides; Thiadiazoles | 2016 |
Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Autophagy; Benzeneacetamides; Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; ErbB Receptors; Erlotinib Hydrochloride; Fluorodeoxyglucose F18; Glutaminase; Glutamine; Humans; Lung Neoplasms; Mice; Mice, SCID; Mutation; Radiopharmaceuticals; RNA Interference; Thiadiazoles; Transplantation, Heterologous | 2017 |
Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia.
Topics: Animals; Benzeneacetamides; Benzothiazoles; Cell Line, Tumor; Female; fms-Like Tyrosine Kinase 3; Glutamic Acid; Glutaminase; Glutamine; Humans; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Mice, Transgenic; Phenylurea Compounds; Thiadiazoles; Xenograft Model Antitumor Assays | 2018 |
Glutaminolysis Promotes Collagen Translation and Stability via α-Ketoglutarate-mediated mTOR Activation and Proline Hydroxylation.
Topics: Actins; Animals; Benzeneacetamides; Cells, Cultured; Collagen; Disease Models, Animal; Elastin; Enzyme Activation; Fibronectins; Glutaminase; Glutamine; Humans; Hydroxylation; Ketoglutaric Acids; Mice; Mice, Inbred C57BL; Myofibroblasts; Proline; Pulmonary Fibrosis; RNA Interference; RNA, Small Interfering; Sulfides; Thiadiazoles; TOR Serine-Threonine Kinases | 2018 |
Glutamine Addiction in Kidney Cancer Suppresses Oxidative Stress and Can Be Exploited for Real-Time Imaging.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Benzeneacetamides; Carcinoma, Renal Cell; Deoxyguanosine; Glutaminase; Glutamine; Humans; Kidney Neoplasms; Mice; NF-E2 Transcription Factor; Oxidative Stress; Reactive Oxygen Species; Thiadiazoles; Xenograft Model Antitumor Assays | 2017 |
Metabolic Differences in Glutamine Utilization Lead to Metabolic Vulnerabilities in Prostate Cancer.
Topics: Benzeneacetamides; Cell Line, Tumor; Glutaminase; Glutamine; Humans; Male; Nuclear Magnetic Resonance, Biomolecular; Prostatic Neoplasms; Thiadiazoles | 2017 |
Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism.
Topics: Allosteric Site; Amino Acid Substitution; Antineoplastic Agents; Benzeneacetamides; Binding, Competitive; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glutaminase; Glutamine; Humans; Hydrogen Bonding; Models, Molecular; Molecular Conformation; Mutation; Neoplasm Proteins; Recombinant Proteins; Sulfides; Thiadiazoles; Triple Negative Breast Neoplasms | 2018 |
Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease.
Topics: Animals; Aquaporin 2; Benzeneacetamides; Cell Proliferation; Cells, Cultured; Female; Glutaminase; Glutamine; Humans; Male; Mice; Mice, Knockout; Polycystic Kidney, Autosomal Dominant; Receptors, Cell Surface; Signal Transduction; Thiadiazoles | 2018 |
Glutaminase 1 regulates the release of extracellular vesicles during neuroinflammation through key metabolic intermediate alpha-ketoglutarate.
Topics: Aniline Compounds; Benzeneacetamides; Benzylidene Compounds; Brain; Calcium-Binding Proteins; Cell Cycle Proteins; Cells, Cultured; Central Nervous System; Ceramides; Dose-Response Relationship, Drug; Endosomal Sorting Complexes Required for Transport; Enzyme Inhibitors; Extracellular Vesicles; Glutamates; Glutaminase; Glutamine; HIV Infections; Humans; Lipopolysaccharides; Macrophages; Membrane Proteins; Microglia; Sulfides; Thiadiazoles | 2018 |
Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation.
Topics: Antineoplastic Agents; Benzeneacetamides; Bone Neoplasms; Chloroquine; Chondrosarcoma; Drug Screening Assays, Antitumor; Glutaminase; Glutamine; Humans; Immunohistochemistry; Isocitrate Dehydrogenase; Metabolic Networks and Pathways; Metformin; Molecular Targeted Therapy; Mutation; Neoplasm Grading; Thiadiazoles; Tumor Cells, Cultured | 2018 |
The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma.
Topics: Animals; Benzeneacetamides; Boron Compounds; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glutamine; Glycine; Glycogen Synthase Kinase 3; Glycolysis; Humans; Ki-67 Antigen; Lung Neoplasms; Mice; Neoplasm Transplantation; Signal Transduction; Thiadiazoles | 2018 |
Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice.
Topics: Animals; Benzeneacetamides; Cell Line, Tumor; Female; Glutaminase; Glutamine; Glutathione; Humans; Lung Neoplasms; Male; Mice; Radiation Tolerance; Thiadiazoles; Xenograft Model Antitumor Assays | 2019 |
Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents; Benzeneacetamides; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Drug Resistance, Neoplasm; Drug Synergism; Energy Metabolism; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; F-Box Proteins; Gene Expression Regulation, Neoplastic; Glutaminase; Glutamine; Humans; Hypoglycemic Agents; Male; Mechanistic Target of Rapamycin Complex 1; Metformin; Mice; Molecular Targeted Therapy; Phenformin; Protein Kinase Inhibitors; Retinoblastoma Protein; Signal Transduction; Thiadiazoles; Xenograft Model Antitumor Assays | 2019 |
Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells.
Topics: Benzeneacetamides; Carnitine O-Palmitoyltransferase; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Female; Glutaminase; Glutamine; Humans; Oxidation-Reduction; Thiadiazoles; Triple Negative Breast Neoplasms; Tumor Cells, Cultured | 2019 |
Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth.
Topics: Benzeneacetamides; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Citric Acid Cycle; Female; Glucose; Glucose Transport Proteins, Facilitative; Glucose Transporter Type 1; Glucose Transporter Type 3; Glutaminase; Glutamine; Glycolysis; Humans; Male; Neoplasms; Thiadiazoles | 2019 |
Knock-down of PSAT1 Enhances Sensitivity of NSCLC Cells to Glutamine-limiting Conditions.
Topics: Activating Transcription Factor 4; Benzeneacetamides; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Gene Knock-In Techniques; Glutaminase; Glutamine; Humans; Lung; Lung Neoplasms; Radiation Tolerance; RNA, Messenger; Thiadiazoles; Transaminases | 2019 |
The activation loop and substrate-binding cleft of glutaminase C are allosterically coupled.
Topics: Allosteric Regulation; Allosteric Site; Amino Acid Substitution; Animals; Benzeneacetamides; Biomedical Engineering; Catalytic Domain; Glutaminase; Glutamine; Kinetics; Mice; Mitochondria; Models, Molecular; Mutation; Protein Isoforms; Protein Structure, Tertiary; Recombinant Proteins; Sulfides; Thiadiazoles | 2020 |
Targeting glutamine metabolism slows soft tissue sarcoma growth.
Topics: Allografts; Animals; Benzeneacetamides; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Glutaminase; Glutamine; Mice; Nucleosides; RNA, Messenger; Sarcoma; Thiadiazoles; Tomography, X-Ray Computed | 2020 |
Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer.
Topics: Benzeneacetamides; Cell Proliferation; Drug Resistance, Neoplasm; Female; Glutaminase; Glutamine; Humans; Pyruvic Acid; Thiadiazoles; Triple Negative Breast Neoplasms; Tumor Cells, Cultured; Tumor Microenvironment | 2020 |
Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzeneacetamides; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Glutaminase; Glutamine; Glutathione; Humans; Mice, Nude; Ovarian Neoplasms; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Proto-Oncogene Proteins c-myc; Thiadiazoles; Xenograft Model Antitumor Assays | 2020 |
A facile and sensitive method of quantifying glutaminase binding to its inhibitor CB-839 in tissues.
Topics: Animals; Benzeneacetamides; Cell Line, Tumor; Colonic Neoplasms; Glutaminase; Glutamine; Heterografts; Humans; Mice; Thiadiazoles | 2020 |
A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer.
Topics: Amino Acid Transport System ASC; Animals; Antineoplastic Agents; Apoptosis; Benzeneacetamides; Carrier Proteins; Cell Line, Tumor; Drug Synergism; Glutaminase; Glutamine; Humans; Liver Neoplasms; Mice; Minor Histocompatibility Antigens; Reactive Oxygen Species; Thiadiazoles; Xenograft Model Antitumor Assays | 2020 |
The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma.
Topics: Anilides; Animals; Benzeneacetamides; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Everolimus; Female; Gene Expression Regulation, Neoplastic; Glucose; Glutaminase; Glutamine; Humans; Kidney Neoplasms; Mice; Pyridines; Signal Transduction; Thiadiazoles; Xenograft Model Antitumor Assays | 2021 |
Heterogeneity of glutamine metabolism in acquired-EGFR-TKI-resistant lung cancer.
Topics: Apoptosis; Benzeneacetamides; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Chromatography, Liquid; Drug Resistance, Neoplasm; ErbB Receptors; Glutamine; Humans; Lung Neoplasms; Mutation; Protein Kinase Inhibitors; Tandem Mass Spectrometry; Thiadiazoles; Xenograft Model Antitumor Assays | 2022 |
Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formation.
Topics: Adaptor Proteins, Signal Transducing; Amino Acid Transport System ASC; Cell Line, Tumor; Cell Proliferation; Glutamine; Humans; Mesothelioma; Mesothelioma, Malignant; Minor Histocompatibility Antigens; Transcription Factors; YAP-Signaling Proteins | 2023 |
Differential Effects of Glutamine Inhibition Strategies on Antitumor CD8 T Cells.
Topics: Animals; CD8-Positive T-Lymphocytes; Diazooxonorleucine; Glutamine; Mice; Neoplasms | 2023 |